[Clinical position of sitafloxacin in outpatient chemotherapy. (discussion)].
Niki
Yoshihito
Y
Aoki
Nobuki
N
Suzuki
Kenji
K
Matsumoto
Tetsuro
T
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D001419:Bacteria / Q000187:drug effects / Q000302:isolation & purification; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D024881:Drug Resistance, Bacterial; D024841:Fluoroquinolones / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D010038:Otorhinolaryngologic Diseases / Q000188:drug therapy* / Q000382:microbiology; D010045:Outpatients; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000382:microbiology; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000382:microbiology
D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; C076246:sitafloxacin